CON Quote, Financials, Valuation and Earnings

Pediatrix Medical Group, Inc. has a net margin of 8.7% compared to Concentra Group Holdings Parent, Inc.'s net margin of 14.55%. Concentra Group Holdings Parent, Inc.'s return on equity of 46.67% beat Pediatrix Medical Group, Inc.'s return on equity of 20.22%.

Concentra Group Holdings Parent, Inc. has a consensus price target of $28.43, signalling upside risk potential of 30.83%. On the other hand Pediatrix Medical Group, Inc. has an analysts' consensus of $22.67 which suggests that it could grow by 2.06%. Given that Concentra Group Holdings Parent, Inc. has higher upside potential than Pediatrix Medical Group, Inc., analysts believe Concentra Group Holdings Parent, Inc. is more attractive than Pediatrix Medical Group, Inc..

Concentra Group Holdings Parent, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pediatrix Medical Group, Inc. has a beta of 0.735, suggesting its less volatile than the S&P 500 by 26.542%.

Concentra Group Holdings Parent, Inc. has a quarterly dividend of $0.06 per share corresponding to a yield of 1.15%. Pediatrix Medical Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentra Group Holdings Parent, Inc. pays 4.81% of its earnings as a dividend. Pediatrix Medical Group, Inc. pays out -- of its earnings as a dividend. Concentra Group Holdings Parent, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Concentra Group Holdings Parent, Inc. quarterly revenues are $572.8M, which are larger than Pediatrix Medical Group, Inc. quarterly revenues of $492.9M. Concentra Group Holdings Parent, Inc.'s net income of $49.8M is lower than Pediatrix Medical Group, Inc.'s net income of $71.7M. Notably, Concentra Group Holdings Parent, Inc.'s price-to-earnings ratio is 18.25x while Pediatrix Medical Group, Inc.'s PE ratio is 11.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent, Inc. is 1.33x versus 0.99x for Pediatrix Medical Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Kindly MD, Inc. has a net margin of 8.7% compared to Concentra Group Holdings Parent, Inc.'s net margin of -22162.75%. Concentra Group Holdings Parent, Inc.'s return on equity of 46.67% beat Kindly MD, Inc.'s return on equity of -91.57%.

Concentra Group Holdings Parent, Inc. has a consensus price target of $28.43, signalling upside risk potential of 30.83%. On the other hand Kindly MD, Inc. has an analysts' consensus of $1.25 which suggests that it could grow by 211.41%. Given that Kindly MD, Inc. has higher upside potential than Concentra Group Holdings Parent, Inc., analysts believe Kindly MD, Inc. is more attractive than Concentra Group Holdings Parent, Inc..

Concentra Group Holdings Parent, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Kindly MD, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Concentra Group Holdings Parent, Inc. has a quarterly dividend of $0.06 per share corresponding to a yield of 1.15%. Kindly MD, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentra Group Holdings Parent, Inc. pays 4.81% of its earnings as a dividend. Kindly MD, Inc. pays out -- of its earnings as a dividend. Concentra Group Holdings Parent, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Concentra Group Holdings Parent, Inc. quarterly revenues are $572.8M, which are larger than Kindly MD, Inc. quarterly revenues of $388.2K. Concentra Group Holdings Parent, Inc.'s net income of $49.8M is higher than Kindly MD, Inc.'s net income of -$86M. Notably, Concentra Group Holdings Parent, Inc.'s price-to-earnings ratio is 18.25x while Kindly MD, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent, Inc. is 1.33x versus 11.25x for Kindly MD, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

The Oncology Institute, Inc. has a net margin of 8.7% compared to Concentra Group Holdings Parent, Inc.'s net margin of -10.08%. Concentra Group Holdings Parent, Inc.'s return on equity of 46.67% beat The Oncology Institute, Inc.'s return on equity of -9486.64%.

Concentra Group Holdings Parent, Inc. has a consensus price target of $28.43, signalling upside risk potential of 30.83%. On the other hand The Oncology Institute, Inc. has an analysts' consensus of $6.50 which suggests that it could grow by 81.06%. Given that The Oncology Institute, Inc. has higher upside potential than Concentra Group Holdings Parent, Inc., analysts believe The Oncology Institute, Inc. is more attractive than Concentra Group Holdings Parent, Inc..

Concentra Group Holdings Parent, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Oncology Institute, Inc. has a beta of 0.151, suggesting its less volatile than the S&P 500 by 84.902%.

Concentra Group Holdings Parent, Inc. has a quarterly dividend of $0.06 per share corresponding to a yield of 1.15%. The Oncology Institute, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentra Group Holdings Parent, Inc. pays 4.81% of its earnings as a dividend. The Oncology Institute, Inc. pays out -- of its earnings as a dividend. Concentra Group Holdings Parent, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Concentra Group Holdings Parent, Inc. quarterly revenues are $572.8M, which are larger than The Oncology Institute, Inc. quarterly revenues of $136.6M. Concentra Group Holdings Parent, Inc.'s net income of $49.8M is higher than The Oncology Institute, Inc.'s net income of -$13.8M. Notably, Concentra Group Holdings Parent, Inc.'s price-to-earnings ratio is 18.25x while The Oncology Institute, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent, Inc. is 1.33x versus 0.67x for The Oncology Institute, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

U.S. Physical Therapy, Inc. has a net margin of 8.7% compared to Concentra Group Holdings Parent, Inc.'s net margin of 9.98%. Concentra Group Holdings Parent, Inc.'s return on equity of 46.67% beat U.S. Physical Therapy, Inc.'s return on equity of 8.6%.

Concentra Group Holdings Parent, Inc. has a consensus price target of $28.43, signalling upside risk potential of 30.83%. On the other hand U.S. Physical Therapy, Inc. has an analysts' consensus of $105.33 which suggests that it could grow by 20.42%. Given that Concentra Group Holdings Parent, Inc. has higher upside potential than U.S. Physical Therapy, Inc., analysts believe Concentra Group Holdings Parent, Inc. is more attractive than U.S. Physical Therapy, Inc..

Concentra Group Holdings Parent, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison U.S. Physical Therapy, Inc. has a beta of 1.290, suggesting its more volatile than the S&P 500 by 28.981%.

Concentra Group Holdings Parent, Inc. has a quarterly dividend of $0.06 per share corresponding to a yield of 1.15%. U.S. Physical Therapy, Inc. offers a yield of 2.06% to investors and pays a quarterly dividend of $0.45 per share. Concentra Group Holdings Parent, Inc. pays 4.81% of its earnings as a dividend. U.S. Physical Therapy, Inc. pays out 95.62% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Concentra Group Holdings Parent, Inc. quarterly revenues are $572.8M, which are larger than U.S. Physical Therapy, Inc. quarterly revenues of $197.1M. Concentra Group Holdings Parent, Inc.'s net income of $49.8M is higher than U.S. Physical Therapy, Inc.'s net income of $19.7M. Notably, Concentra Group Holdings Parent, Inc.'s price-to-earnings ratio is 18.25x while U.S. Physical Therapy, Inc.'s PE ratio is 36.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent, Inc. is 1.33x versus 1.75x for U.S. Physical Therapy, Inc.. Usually stocks with elevated PS ratios are considered overvalued.